Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003.

Clarke, N W and Ali, A and Ingleby, F C and Hoyle, A and Amos, C L and Attard, G and Brawley, C D and Calvert, J and Chowdhury, S and Cook, A and Cross, W and Dearnaley, D P and Douis, H and Gilbert, D and Gillessen, S and Jones, R J and Langley, R E and MacNair, A and Malik, Z and Mason, M D and Matheson, D and Millman, R and Parker, C C and Ritchie, A W S and Rush, H and Russell, J M and Brown, J and Beesley, S and Birtle, A and Capaldi, L and Gale, J and Gibbs, S and Lydon, A and Nikapota, A and Omlin, A and O'Sullivan, J M and Parikh, O and Protheroe, A and Rudman, S and Srihari, N N and Simms, M and Tanguay, J S and Tolan, S and Wagstaff, J and Wallace, J and Wylie, J and Zarkar, A and Sydes, M R and Parmar, M K B and James, N D (2020) Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003. Annals of oncology : official journal of the European Society for Medical Oncology, 31 (3). p. 442. ISSN 1569-8041.

Full text not available from this repository.
Official URL: https://www.sciencedirect.com/science/article/pii/...
Item Type: Article
Subjects: QZ Pathology. Oncology
WJ Urogenital system. Urology
Divisions: Clinical Support > Radiology
Planned IP Care > Oncology and Clinical Haematology
Related URLs:
Depositing User: Mrs Yolande Brookes
Date Deposited: 21 Feb 2020 14:19
Last Modified: 21 Feb 2020 14:19
URI: http://www.repository.uhblibrary.co.uk/id/eprint/2869

Actions (login required)

View Item View Item